TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
GH

Guardant Health Inc

Healthcare · Diagnostics & Research

177.30$ +0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow GH
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-145.4% -144.9% -79.6% -22.0% -36.2% -55.9% -68.8% -57.6% -32.5% -18.8%
14.6% 10.4% 7.9% 5.3% 5.6% 6.0% 8.0% 7.6% 5.7% 4.0%
7.8% 7.4% 7.6% 7.9% 50.3% 40.5% 21.1% 16.1% 19.0% 16.9%
13.0% 21.6% 7.5% 8.0% 52.7% 41.2% 23.2% – – –
9.7% -10.0% -1.2% -3.9% -16.6% -10.8% 13.7% 9.5% -8.2% -1.5%
7.0% 18.0% 22.3% 9.9% 18.9% 20.1% 17.2% 3.6% 4.7% 4.9%
103.8% -341.9% -168.8% -148.1% -215.2% -16.9% 33.3% 149.0% -35.4% -63.9%
– – 3.5% – 2.5% 4.8% – – – –
-0.4% -14.5% -0.2% -0.3% 2.5% -22.4% -1.8% 1.8% 1.6% -4.6%
-1.5% -52.3% -0.5% -0.1% 363.7% -0.2% 0.0% 0.0% 0.0% 41.0%
157.8% 565.1% 323.4% 171.3% 491.9% -17.9% -42.1% 84.6% -0.1% 68.3%
116.2% 78.3% 75.0% 1.3% 240.6% -91.2% -77.9% 175.9% -68.2% -14.3%
-152.4% -163.0% -101.9% -31.9% -55.1% -76.0% -86.1% -61.3% -37.2% -23.7%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?